Commentary

Tools for rapid preoperative cardiovascular risk assessment

Author and Disclosure Information

Prediction is very difficult, especially about the future.
Niels Bohr


 

References

Stating that a patient is “cleared for surgery” is no longer considered adequate; rather, the patient should be assessed for surgical risk, a major component of which is cardiovascular risk. The risk level helps the surgical team determine which preoperative, intraoperative, and postoperative assessments and therapies are indicated.1

Clinical decision tools to assist physicians perform preoperative cardiovascular assessment have been developed and validated, and some have been adapted to handheld computers (Table 1).1-8 Yet few prospective or randomized studies have been conducted to establish the value of various preoperative assessment strategies on outcome.1 In this report, we review the studies underlying these rules and the corresponding software programs for handheld computers (also known as personal digital assistants, or PDAs). Our goal is to find readily applicable software that assists physicians in performing rapid preoperative cardiovascular assessment of patients in the office or hospital.

Cardiovascular Decision Tools

Some cardiovascular decision tools, such as those developed by the American College of Physicians (ACP) and American College of Cardiology/American Heart Association (ACC/AHA), are algorithmic approaches that make direct recommendations about whether to pursue cardiac testing. These tools are designed to be widely applicable to potential candidates for noncardiac surgery.

Other decision tools provide a risk score or index, which the user must interpret and translate into perioperative recommendations. The physician must also assure that the index is appropriate to the patient being evaluated by considering the original study’s patient selection criteria, the setting in which the rule was validated (eg, referral center), and which outcomes the rule predicts. Table 2provides more detailed information about each rule, as well as an assessment of each rule’s methodologic rigor (adapted from methodologic standards for clinical prediction rules developed by Wasson et al10).

Limitations

Even when applied correctly, these indices have substantial limits. The positive predictive values (percentage of patients predicted to have complications who actually suffer a complication) are generally low and, especially in the case of higher-risk surgery, a low risk score does not eliminate the risk of complications.2

It is therefore important to consider the overall risk of adverse outcomes for patients undergoing a particular kind of surgery (the “pretest probability”): the same patient planning cataract surgery and vascular surgery has 2 distinctly different risks, despite having the same score on the biomedical components of the index. Also, these decision support tools were developed using information from patients enrolled during past decades, and their results may not be directly applicable to current surgical risks.4 Finally, these indices cannot be used on all patients. For example, a patient with a rare or unusual problem such as left atrial myxoma may be at a higher risk than would otherwise be indicated by one of the decision support tools.3

TABLE 1
Program information

AlgorithmProgramVersionSizeCostSource
ACC/AHA1 2002STAT Cardiac Clearance1.197 KBFreehttp://www.statcoder.com
Detsky3MedRules2.5324 KBFreehttp://pbrain.hypermart.net/
Detsky6InfoRetriever4.2 (beta)2.1 MBBeta is free;cost of final version unknownhttp://www.infopoems.com

TABLE 2
Selected characteristics of studies of perioperative risk assessment

Decision ruleStudy population characteristics Derivation and validation set sample size; years of enrollmentProspective data collection and reviewer blindingMajor outcomes measured and number of outcomesPretest probabilities†
ACC/AHA1All noncardiac surgery, major & minorN/A / N/A Evidencebased guidelineN/AN/AN/A
ACP2All noncardiac surgery, major & minorN/A / N/A Evidence based consensus guidelineN/AN/AN/A
Detsky3,6All noncardiac surgery, major & minor, at a large teaching hospital. Patients were 40 years and older, referred by the surgical services for consultation because of a question of cardiac risk or chronic disease.aNot specified/ 455; Enrollment years not specifiedBlinded,* prospective collection of validation dataCardiac death, nonfatal myocardial infarction, ventricular tachycardia or fibrillation requiring counter shock, and nonfatal alveolar pulmonary edema;30 outcomes occurred3Major surgery
  • Vascular 13.2%/21%
  • Orthopedic 13.6%/18.2%
  • Intrathoracic/intraperitoneal 8.0%/12.6%
  • Head and neck 2.6%/7.8%
Minor surgery 1.6%/2.1% (eg, TURP, cataracts)
Mangano/Goldman4,9Consecutive unselected patients at a large teaching hospital. Patients were 40 years and older; patients with angina or those undergoing minor surgery were excludedb1001/None; 1975–1976Derivation set data not uniformly prospective; blinding not mentionedMyocardial infarction,pulmonary edema, ventricular tachycardia; 58 outcomes occurred5.8%
Lee5All patients at a large teaching hospital, 50 years and older, with an anticipated surgical length of stay ≥ 2 daysc2893/1422; 1989–1994Blinded, prospective collection of derivation and validation set dataMyocardial infarction,pulmonary edema, ventricular fibrillation or cardiac arrest, complete heart block; 36 outcomes occurred2.5%
Steyerberg7Consecutive patients for primary elective abdominal aortic aneurysm surgery at a university hospital in the Netherlandsd238/None; 1977–1988Unclear whether data collection was prospective and whether reviewer was blindedSurgical mortality; 18 deaths7.6%
L’Italien8Consecutive vascular surgery patients at 5 teaching hospitals referred to their respective institutions’ nuclear cardiology laboratory for preoperative ipyridamole-thallium testing.e567/514; 1988–1991Derivation data collection was retrospective; validation data collection was prospective. Unclear whether reviewer was blindedCardiac death, fatal/nonfatal myocardial infarction, not pulmonary edema or congestive heart failure; 39 outcomes occurredSurgical typeTraining/Validation sets
Aortic6% / 6%
Infrainguinal13% / 10%
Carotid6% / 6%
Total8% / 8%
All studies described the mathematical model used in constructing the decision rule. None of the studies reported measuring the clinical effect of applying the decision rule. It is evident most rules are based on studies with methodologic concerns and relatively small numbers of target outcomes. The small numbers of outcome events in any 1 subgroup, group, or study means that a difference of 1 or 2 more or fewer outcomes could substantially change the reported results, especially the pretest probability.
*Blinding of postoperative evaluators to preoperative information and classification.
Overall rate in study of target outcomes when more specific data are not available.
First percentage: Rate of cardiac death, myocardial infarction, pulmonary edema; second percentage additionally includes worsened coronary insufficiency and congestive heart failure without pulmonary edema.
a. "Not a sample of consecutive patients undergoing surgery, and, therefore, our pretest probabilities will be higher than those that would be found in [a consecutive series]."
b. Because 1977 data excluded minor surgery, unclear how 1995 revision was constructed to include patients undergoing minor procedures. Subject to ascertainment bias because all patients were not studied postoperatively for silent myocardial infarction and other complications.
c. Validation set performed poorly for abdominal aortic aneurysm surgery; authors speculated low number of patients (~100) in derivation set responsible.
d. Patient sample from Netherlands. 238 patients represents "core" because authors used "unique" methods ("We used a new statistical method to quantify the combined effect...") that may be subject to question to "expand" their sample size beyond the actual number of patients studied.
e. Applicable to vascular surgery candidates who require preoperative nuclear stress tests.
N/A, not applicable, none or not specified, not available; TURP, transurethral prostatectomy.

Pages

Recommended Reading

Warfarin plus aspirin more effective than aspirin alone for secondary prevention of MI
MDedge Family Medicine
Should patients with coronary disease and high homocysteine take folic acid?
MDedge Family Medicine
Early invasive strategy for acute cardiac ischemia is cost effective
MDedge Family Medicine
Detriments of tPA for acute stroke in routine clinical practice
MDedge Family Medicine
Digoxin increases mortality among women with congestive heart failure
MDedge Family Medicine
HRT and vitamins C and E do not improve coronary disease in women
MDedge Family Medicine
What are the risks of long-term NSAIDs and COX-2 inhibitors?
MDedge Family Medicine
Is rate control better than rhythm control for atrial fibrillation in older high-risk patients?
MDedge Family Medicine
Does magnesium therapy early in acute MI reduce mortality?
MDedge Family Medicine
Does C-reactive protein predict cardiovascular events in women better than LDL?
MDedge Family Medicine